XORTX Therapeutics (XRTX) )XRTX) welcomes Dr. Michael Bumby as its Chief Financial Officer replacing James Fairbairn, the Company’s current Chief Financial Officer. Dr. Bumby, DVM, MBA, is currently a director and audit committee chair of MediPharm Labs (MEDIF) following their successful acquisition of VIVO Cannabis. where Dr. Bumby was CFO for six years.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRTX: